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Parameters of water diffusion in white matter derived from diffusion-weighted imaging
(DWI), such as fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, and
RD), and more recently, peak width of skeletonized mean diffusivity (PSMD), have been
proposed as potential markers of normal and pathological brain ageing. However, their
relative evolution over the entire adult lifespan in healthy individuals remains partly
unknown during early and late adulthood, and particularly for the PSMD index. Here,
we gathered and analyzed cross-sectional diffusion tensor imaging (DTI) data from 10
population-based cohort studies in order to establish the time course of white matter
water diffusion phenotypes from post-adolescence to late adulthood. DTI data were
obtained from a total of 20,005 individuals aged 18.1 to 92.6 years and analyzed with the
same pipeline for computing skeletonized DTI metrics from DTI maps. For each individual,
MD, AD, RD, and FA mean values were computed over their FA volume skeleton, PSMD
being calculated as the 90% peak width of the MD values distribution across the FA
skeleton. Mean values of each DTI metric were found to strongly vary across cohorts,
most likely due to major differences in DWI acquisition protocols as well as pre-processingg May 2020 | Volume 11 | Article 3421
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Frontiers in Psychiatry | www.frontiersin.orand DTI model fitting. However, age effects on each DTI metric were found to be highly
consistent across cohorts. RD, MD, and AD variations with age exhibited the same
U-shape pattern, first slowly decreasing during post-adolescence until the age of 30, 40,
and 50 years, respectively, then progressively increasing until late life. FA showed a
reverse profile, initially increasing then continuously decreasing, slowly until the 70s, then
sharply declining thereafter. By contrast, PSMD constantly increased, first slowly until the
60s, then more sharply. These results demonstrate that, in the general population, age
affects PSMD in a manner different from that of other DTI metrics. The constant increase in
PSMD throughout the entire adult life, including during post-adolescence, indicates that
PSMD could be an early marker of the ageing process.Keywords: ageing, white matter, neurodegeneration, MRI, diffusion, PSMDINTRODUCTION
Parameters of water diffusion in white matter derived from
diffusion-weighted imaging (DWI), such as fractional
anisotropy (FA), mean, axial, and radial diffusivity (MD, AD,
and RD) are well-established markers of normal brain
maturation (1–5) and ageing (6–12) and have been proposed
as potential tools for the investigation of various brain disorders
(13–19).
More recently, peak width of skeletonized mean diffusivity
(PSMD) (20), a new phenotype of white matter microstructure
that can be derived from DWI, has been proposed as an imaging
biomarker of small vessel disease (SVD) (20, 21) and a correlate
of cognitive impairment, particularly processing speed (20–22).
Recall that PSMD is the difference between the 5th and the 95th
percentiles of the distribution of the voxel MD value across a
skeleton of the brain white matter. Note that PSMD is a
dispersion statistic, as opposed to other diffusion tensor
imaging (DTI) metric, such as AD, MD, RD, and FA, that are
central tendency statistics. So far, our knowledge of the PSMD
distribution in healthy individuals has been limited to these three
previously mentioned studies that all included people aged over
50 years. In addition, none of these studies addressed the issue of
changes in PSMD across lifespan, which is critical for
establishing whether PSMD could be used as an imaging
marker of brain aging as well as an early predictor of age-
related disorders or to serve as a tool to monitor outcomes in
clinical trials. Here, we gathered and analyzed cross-sectional
DTI data from 10 population-based cohort studies to establish
the time course, from post-adolescence to late adulthood, of the
PSMD distribution and compare it with that of more commonly
used white matter water diffusion phenotypes in white matter.MATERIALS AND METHODS
Participants
Ten independent data sets coming from cross-sectional cohort
studies were gathered in the present study, namely, MRi-Share,
BIL&GIN, SYS, LIFE-Adult, 1000 BRAINS, UKBiobank, ASPSF,g 2OATS, LBC1936, MAS (see acronym definition in Table 1
caption). All but three (LIFE-Adult, 1000BRAINS, and
UKBiobank) were part of the BRIDGET Consortium (BRain
Imaging, cognition, Dementia, and next generation GEnomics: a
Transdisciplinary approach to search for risk and protective
factors of neurodegenerative disease), supported by EU-JPND
(European Union Joint Programme—Neurodegenerative
Disease Research). The 10 data sets included a total of 20,005
individuals (age range, 18.1 to 92.6 years; 10,807 women and
9,198 men). Table 1 detail sample size and age distribution for
the 10 cohorts that were all of cross.Diffusion-Weighted Image Acquisition and
Preprocessing
Table 2 summarize the main characteristics of the DWI
acquisition and preprocessing for the 10 cohorts. Overall, there
was considerable variability between studies regarding almost all
acquisition parameters, including scanner manufacturer, field
strength, gradient strength, diffusion pulse sequence, resolution,
and number of directions. For the present work, it was not
possible to access raw DWI data at different sites in order to
harmonize processing from the initial DICOM data. For this
reason, DWI data sets were pre-processed with procedures
specific to each site, including exclusion of data upon visual
detection of major artifacts due to eddy current distortions or
head motion. AD, RD, MD, and FA maps were computed by
fitting the DTI model parameters in each voxel from these
preprocessed DWI volumes. Additional details on DWI
preprocessing and DTI parameter map computation for each
data set are provided in the Supplementary Material section.Derivation of DTI Metrics
Various metrics were derived from the DTI data using a script
developed by Baykara et al. (http://www.psmd-marker.com)
(20). This original script was designed to extract PSMD, an
index of the dispersion of MD values across the white matter
skeleton. Briefly, the computation included two steps: 1) WM
skeletonizing using the FA map, and 2) analyzing the voxel value
distribution histogram in the MD volume masked by the WM-May 2020 | Volume 11 | Article 342
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Beaudet et al. PSMD Changes Across Adult LifeFA skeleton. The 3D brain image of FA of each individual was
skeletonized using the FSL-TBSS software, part of the FMRIB
Software Library (FSL) (23, 24), using the FMRIB 1 mm FA
template and applying a 0.2 threshold on FA maps. Then the MD
volume of the same individual was masked, keeping only voxels
within the FA skeleton. Furthermore, in order to reduce
contamination of the skeleton by CSF voxels, the FA-masked
MD volumes were further masked by both a standard FA
skeleton with a threshold of 0.3 on FA values and a custom
mask (provided with the PSMD software tool) designed so as to
exclude regions adjacent to the ventricles, such as the fornix.
Finally, PSMD was computed as the difference between the 95th
and 5th percentiles of the so-masked MD volume voxel value
distribution. Here, we extended this script in order to obtain, in
addition to PSMD values, estimates of the mean values of axial,
radial, and mean diffusivity (AD, RD, MD, respectively) as well
as of FA over the same customized skeleton. All 10 cohorts were
processed separately with this customized script, and the results
were sent to the Bordeaux site where they were combined for
further statistical analysis.
Statistical Analyses
Age Category Definition
Due to previously reported non-linear effects of age on DTI
metrics (1, 3, 8), we divided each cohort sample into subsamples
of 10-year age range starting at 18 years of age, the last subsample
(i.e. [78 to 98]) including all subjects older than 78 years, as there
was only a small number of individuals older than 88 years.
Table 1 and Figure 1 detail the contribution of each cohort to
each age category. Because we planned running analyses at the
age category by cohort by sex level, we discarded subsamples of
small sizes, namely, containing less than 30 individuals.
Assessing Age-Related Changes of PSMD
and Other DTI Metrics
For each of the five DTI metrics and each age category, we
performed an analysis of variance including “age” as the main
effect, and “sex,” total intracranial volume (TIV), and “Cohort”
as confounding factors. The Cohort effect was included in order
to account for apparent large differences in DTI metric averageFrontiers in Psychiatry | www.frontiersin.org 4values across cohorts contributing to the same age category data
set (see Figure 2). “Sex” and “TIV” were included as covariates
since mixed results have been reported regarding the impact of
sex and TIV on DTI measures [(12, 25–28), see review in (3)]. In
order to document differences of age effects between cohorts
contributing to the same age category, we also performed an
analysis of variance for each age category and each cohort,
including “age,” “sex,” and “TIV” as effects. Moreover, we
analyzed the effects of age on DTI metrics in men and
women separately.
Assessing the Effects of Sex and TIV on PSMD and
Other DTI Metrics
For each of the five DTI metrics and each age category, we also
performed an analysis of variance including “Sex” and “TIV” as
main factors and “Cohort” as confounding factors.
All statistical analyses were performed using the JMP Pro
Software (version 14.3.0, SAS Institute Inc.).RESULTS
Descriptive Statistics
Tables 3A–E provide basic statistics across age categories and
cohorts for PSMD and the four other DTI metrics, while Figure
2 illustrates their respective profiles across the adult lifespan.
From both Table 3 and Figure 2, it is apparent that there is
considerable variability in all five DTI parameter values, and that
within a given age category the variability across cohorts is larger
than the variability between individuals of the same cohort (see
the extreme case of AD and FA values for the LBC1936 study
performed at 1.5T, for example).
Figure 3 compares the inter-individual variability of PSMD
(in terms of its coefficient of variation, CV in %) within each
cohort to those of the other DTI metrics, again for each age
category and each cohort, revealing that PSMD CV's is in the
order of 10% to 15% (with values as high as 20% for later ages)
while those for AD, RD, MD, and FA are in the order of 2% to
5%. Note also that the CVs of all DTI metrics increase with age,
more for PSMD than for the other parameters.FIGURE 1 | Box-plots and histogram distribution of the age of the participants of the 10 contributing data sets.May 2020 | Volume 11 | Article 342
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Metrics
The evolution of PSMD across the adult life is different from that
of the other metrics (Figure 2). Indeed, PSMD seems to increase
monotonically with age, whereas AD, RD, and MD exhibit a
similar J-shape profile, initially slightly decreasing during post-
adolescence before later increasing during adulthood. As for FA,
it shows a reverse profile to that of AD, RD, and MD, with an
initial small increase followed by a later decrease.
This apparent specific lifespan profile of PSMD was
confirmed by the quantitative estimates of the effects of age on
PSMD and other DTI metrics provided by the between-cohort
ANOVA (see Table 4) and their profiles of evolution across age
categories as shown in Figure 4. Estimates of the age effect on
PSMD were indeed positive for all age categories and significant
for all but the 28- to 38-year age period. This increase in PSMD
accelerated during late life periods, its value being multiplied by a
factor of 3 between the 58- to 68-year and the 78- to 98-year
periods. By contrast, AD, RD, and MD age variation profiles
were characterized by an initial small but significant decrease
(negative age effect), followed by a stable period (non-significant
age effect) and a final significant increase (positive age effect).
What distinguished AD, RD, and MD profiles was their
respective timings, the initial decrease in RD and MD being
significant only for the 18 to 28 years subsample, while it
extended over the 38- to 48-year period for AD. Note that
since the stable period covered two periods of 10 years for all
three metrics, the increase in AD was delayed by 10 years
compared with RD and MD. At the same time, FA exhibited
the reverse contrast consisting of an initial increase during the
18- to 28-year period followed by a stable period (28 to 38 years)
before an accelerated decrease during the rest of the adult life
course. The age effects on DTI metrics were not significantlyFrontiers in Psychiatry | www.frontiersin.org 5different between men and women as revealed by the separate
sex-specific analyses of age effects.
Effects of Sex and TIV on DTI
Amplitude of sex effects on DTI metric average values were
found to be quite variable across the various cohorts for the
different age categories (see Figure 5). When pooling all data
sets, we found that sex had significant effects on all DTI
parameters except on FA. Women had higher mean AD and
MD values than men, who conversely had higher PSMD values
than women (see Table 5). As for TIV, we found that it had
positive effects on all DTI parameters (see Table 5), including
PSMD, these effects being very significant (p < 10−4) in all cases
but RD (p = 0.53).DISCUSSION
We will first discuss methodological issues and potential
limitations in interpreting results of our study. Second, we will
discuss what the present study adds to the already existing
literature on age effects on classical DTI parameters. In the
third part, we will focus on the original findings regarding
PSMD distribution and evolution over the adult life.
Methodological Issues and Potential
Limitations of the Present Study
In order to study the effects of age over the entire adult lifespan,
we gathered DTI data from 20,005 individuals scanned at 10
different sites with the major objective of maximizing statistical
power. By so doing, we were aware that the variability of DTI
parameters derived from the entire data set would be much largerFIGURE 2 | Mean and standard deviation (bars) of the five DTI metrics for each age subcategory and each data set. The dotted lines connect values for the different
age categories of the same data set.May 2020 | Volume 11 | Article 342
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Frontiers in Psychiatry | www.frontiersin.org 6than for a single-site study because of between-site differences in
data acquisition protocols, such as scanner manufacturer, field
strength, number and strength of diffusion-encoding gradients,
image voxel size, post-processing of raw DWI data, and so on
(23, 24, 29–32). Accordingly, a key issue was to reduce as much
as possible the variability due to sources that were controllable so
that we could maximize benefits of the very large sample size.
Concerns with DTI multi-site studies have been emphasized
by several authors (33, 34) and strategies have been proposed for
harmonizing DWI data before proceeding to statistical analysis
of DTI parameter maps. However, it has also been reported that
DTI parameters estimated over the whole white matter or large
regions of interest actually exhibit high intra- and inter-scanner
reproducibility, making them suitable for multisite studies
without extensive harmonization (17, 35, 36). This is the
approach that we implemented here as it was not possible to
access raw DWI data at different sites in order to harmonize
processing from the very earliest stages (see Supplementary
Materials). In our study, harmonization was limited to the
post-processing of DTI maps pre-computed by each site using
the same script for generating individual skeletons and
computing individual DTI parameter values across these
skeletons. However, our findings indicate that it is possible to
draw meaningful conclusions from such minimal harmonization
by focusing on the effects of interest (age in our case) rather than
the absolute values of the measurements, an approach previously
used by others (37).
Multi-site studies do have some advantages as compared with
single-site investigations, namely, statistical power due to very
large sample size, and the ability to recruit a sufficient number of
individuals over the entire life or adult lifespan. As emphasized
by others, these are important features in the context of clinical
studies that are often multisite in nature (17, 35). In fact, there
have been several previous reports of multisite studies on DTI
parameters in adults but they dealt with issues other than age
effects such as methodology (17, 30, 33) and genetic effects (38,
39), for example.
In this study, we focused on the mean DTI metrics over a
white matter skeleton, rather than over the entire white-matter
compartment, since our primary metric of interest was PSMD,
which is defined over the FSL-TBSS white matter skeleton
derived from FA data. This approach should in theory
minimize any partial volume effects by limiting the
measurement over the core of white matter tracts. Indeed,
when we compared the mean DTI metrics over the white
matter skeleton with those measured over the whole white-
matter compartment in two cohorts of the study (MRi-Share
and BIL&GIN), mean FA values were higher and diffusivity
values were lower when averaged over the white matter skeleton
than when averaged over the entire white-matter compartment.
However, the cross-subject variability measured as the CV of the
mean DTI metrics decreased only marginally (a fraction of a
percent for CVs ranging from 2% to 4%) when mean values were
computed over the white matter skeleton rather than the whole
white matter. In contrast, the CV of PSMD decreased markedly
(on average, from 24% to 8%) when its computation wasT
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Beaudet et al. PSMD Changes Across Adult LifeTABLE 3B | Basic statistics of radial diffusivity (RD, in mm2 s−1 × 10−4) average across a white matter skeleton for each age category and each contributing data set.
Age range MRi-Share BIL&GIN SYS LIFE 1000 BRAINS UKBiobank ASPSF OATS LBC 1936 MAS
18 to 28 4.74 (0.18)
[4.15, 5.53]
4.81 (0.19)
[4.26, 5.44]
4.83 (0.19)
[4.33, 5.29]
4.66 (0.18)
[4.26, 5.19]
28 to 38 4.72 (0.21)
[4.35, 5.10]
4.79 (0.20)
[4.45, 5.56]
4.83 (0.20)
[4.42, 5.36]
4.60 (0.18)
[4.20, 5.17]
38 to 48 4.83 (0.22)
[4.49, 5.27]
5.45 (0.24)
[4.88, 6.36]
4.87 (0.22)
[4.35, 5.59]
4.64 (0.20)
[4.28, 5.27]
4.95 (0.22)
[4.19, 5.64]
5.11 (0.29)
[4.54, 5.79]
48 to 58 5.51 (0.25)
[4.93, 6.54]
4.99 (0.24)
[4.47, 6.01]
4.72 (0.22)
[4.21, 5.38]
4.97 (0.23)
[4.17, 6.22]
5.22 (0.30)
[4.57, 6.05]
58 to 68 5.58 (0.31)
[5.02, 6.27]
5.13 (0.29)
[4.29, 6.36]
4.84 (0.25)
[4.21, 5.57]
5.08 (0.26)
[4.34, 6.40]
5.47 (0.37)
[4.73, 6.59]
5.27 (0.38)
[4.36, 6.05]
68 to 78 5.31 (0.33)
[4.48, 6.73]
4.99 (0.31)
[4.16, 6.29]
5.21 (0.29)
[4.29, 7.10]
5.49 (0.35)
[4.85, 6.69]
5.40 (0.46)
[4.44, 6.77]
5.21 (0.38)
[4.28, 8.87]
5.66 (0.34)
[5.05, 6.78]
78 to 98 5.37 (0.33)
[4.87, 6.31]
5.19 (0.37)
[4.69, 5.99]
5.36 (0.20)
[5.03, 5.69]
5.75 (0.48)
[4.80, 7.08]
5.81 (0.40)
[4.88, 7.17]Frontiers in Psychiatry | www.frontiersin.org 7 May 2020 | Volume 11 |Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).TABLE 3C | Basic statistics of mean diffusivity (MD, in mm2 s−1 × 10−4) average across a white matter skeleton for each age category and each contributing data set.
Age range MRi-Share BIL&GIN SYS LIFE 1000 BRAINS UKBiobank ASPSF OATS LBC 1936 MAS
18 to 28 7.09 (0.16)
[6.54, 7.76]
7.44 (0.17)
[7.02, 7.98]
7.35 (0.18)
[6.89, 7.75]
6.97 (0.17)
[6.54, 7.34]
28 to 38 7.04 (0.18)
[6.64, 7.38]
7.39 (0.17)
[7.08, 7.97]
7.33 (0.18)
[6.92, 7.78]
6.87 (0.19)
[6.43, 7.39]
38 to 48 7.37 (0.20)
[7.05, 7.80]
7.50 (0.21)
[6.98, 8.17]
7.33 (0.20)
[6.81, 7.84]
6.87 (0.19)
[6.42, 7.39]
7.37 (0.22)
[6.38, 8.05]
7.37 (0.25)
[6.97, 8.01]
48 to 58 7.53 (0.23)
[6.97, 8.45]
7.41 (0.22)
[6.89, 8.31]
6.92 (0.21)
[6.35, 7.58]
7.39 (0.22)
[6.17, 8.42]
7.45 (0.27)
[6.91, 8.26]
58 to 68 7.61 (0.27)
[7.09, 8.20]
7.53 (0.26)
[6.82, 8.64]
7.01 (0.25)
[6.35, 7.78]
7.47 (0.24)
[6.41, 8.67]
7.66 (0.34)
[6.98, 8.58]
7.43 (0.41)
[6.55, 8.18]
68 to 78 7.70 (0.30)
[6.93, 8.92]
7.16 (0.29)
[6.30, 8.39]
7.59 (0.27)
[6.43, 9.23]
7.68 (0.33)
[6.51, 8.74]
7.54 (0.48)
[6.57, 8.91]
6.74 (0.35)
[5.79, 7.86]
7.72 (0.31)
[7.14, 8.71]
78 to 98 7.74 (0.31)
[7.23, 8.61]
7.34 (0.34)
[6.84, 8.15]
7.72 (0.20)
[7.34, 8.01]
7.87 (0.51)
[6.92, 9.21]
7.86 (0.36)
[6.96, 9.06]Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).TABLE 3D | Basic statistics of peak width skeletonized mean diffusivity (PSMD, in mm2 s−1 × 10−4) for each age category and each contributing data set.
Age range MRi-Share BIL&GIN SYS LIFE 1000 BRAINS UKBiobank ASPSF OATS LBC 1936 MAS
18 to 28 1.54 (0.14)
[1.20, 2.13]
2.13 (0.17)
[1.75, 2.78]
2.02 (0.19)
[1.68, 2.53]
2.26 (0.28)
[1.86, 3.47]
28 to 38 1.58 (0.17)
[1.33, 2.01]
2.18 (0.22)
[1.75, 2.85]
2.05 (0.19)
[1.65, 2.63]
2.32 (0.24)
[1.75, 3.00]
38 to 48 2.24 (0.18)
[1.89, 2.58]
2.68 (0.30)
[2.07, 4.44]
2.17 (0.22)
[1.64, 3.00]
2.49 (0.29)
[1.94, 3.46]
2.10 (0.22)
[1.60, 3.11]
2.63 (0.39)
[1.95, 3.53]
48 to 58 2.82 (0.34)
[1.99, 5.12]
2.31 (0.28)
[1.70, 3.63]
2.67 (0.32)
[2.03, 4.07]
2.12 (0.25)
[1.49, 4.58]
2.69 (0.36)
[2.18, 3.70]
58 to 68 2.92 (0.30)
[2.51, 3.57]
2.53 (0.38)
[1.83, 4.85]
2.94 (0.38)
[2.14, 5.03]
2.27 (0.31)
[1.56, 5.71]
2.82 (0.49)
[2.15, 4.54]
2.96 (0.54)
[2.11, 4.90]
68 to 78 2.78 (0.47)
[1.88, 5.26]
3.26 (0.47)
[2.23, 5.53]
2.48 (0.39)
[1.61, 6.19]
3.17 (0.49)
[2.15, 4.60]
3.10 (0.64)
[2.17, 6.66]
3.18 (0.53)
[2.09, 5.72]
3.84 (0.61)
[2.56, 6.02]
78 to 98 2.96 (0.45)
[2.15, 3.94]
3.68 (0.58)
[2.83, 5.32]
2.74 (0.33)
[2.10, 3.45]
3.77 (0.90)
[2.47, 6.51]
4.29 (0.77)
[2.95, 7.96]Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).Article 342
Beaudet et al. PSMD Changes Across Adult LifeTABLE 3E | Basic statistics of fractional anisotropy (FA, unitless) average across individual FA skeleton for each age range category and each contributing data set.
Age range MRi-Share BIL&GIN SYS LIFE 1000 BRAINS UKBiobank ASPSF OATS LBC 1936 MAS
18 to 28 0.53 (0.01)
[0.47, 0.58]
0.56 (0.01)
[0.51, 0.60]
0.54 (0.02)
[0.49, 0.58]
0.54 (0.01)
[0.49, 0.56]
28 to 38 0.53 (0.02)
[0.49, 0.56]
0.55 (0.02)
[0.50, 0.58]
0.54 (0.02)
[0.50, 0.58]
0.54 (0.01)
[0.49, 0.57]
38 to 48 0.55 (0.02)
[0.52, 0.57]
0.46 (0.02)
[0.39, 0.50]
0.54 (0.02)
[0.48, 0.58]
0.53 (0.02)
[0.48, 0.56]
0.53 (0.01)
[0.49, 0.56]
0.51 (0.02)
[0.46, 0.55]
48 to 58 0.45 (0.02)
[0.40, 0.50]
0.53 (0.02)
[0.46, 0.57]
0.52 (0.02)
[0.47, 0.58]
0.52 (0.02)
[0.44, 0.57]
0.49 (0.02)
[0.42, 0.54]
58 to 68 0.45 (0.02)
[0.41, 0.49]
0.52 (0.02)
[0.44, 0.58]
0.51 (0.02)
[0.46, 0.57]
0.52 (0.02)
[0.44, 0.57]
0.48 (0.02)
[0.41, 0.53]
0.48 (0.02)
[0.43, 0.55]
68 to 78 0.51 (0.02)
[0.40, 0.56]
0.51 (0.02)
[0.44, 0.56]
0.51 (0.02)
[0.37, 0.57]
0.48 (0.02)
[0.41, 0.53]
0.48 (0.03)
[0.38, 0.54]
0.41 (0.03)
[0.31, 0.47]
0.45 (0.02)
[0.36, 0.49]
78 to 98 0.50 (0.02)
[0.45, 0.54]
0.50 (0.02)
[0.44, 0.53]
0.50 (0.01)
[0.48, 0.52]
0.46 (0.02)
[0.40, 0.51]
0.45 (0.03)
[0.34, 0.51]Frontiers in Psychiatry | www.frontiersin.org 8 May 2020 | Volume 11 |Values are mean (S.D. and range [min, max] across the age category sample (see Table 1 legend for the meaning of data set abbreviated names).FIGURE 3 | Coefficients of variation of the five DTI metrics for each age subcategory and each data set.TABLE 4 | ANOVA effect of age (estimate (standard error) and significance p-value) on five DTI metrics (AD, RD, MD, PSMD, and FA evaluated across individual FA
skeletons).
Age range (years) AD RD MD PSMD FA
estimate p estimate p estimate p estimate p estimate p
18 to 28 −2.01 (0.20) <0.0001 −1.06 (0.18) <0.0001 −1.38 (0.17) <0.0001 0.41 (0.15) 0.0058 0.30 (0.15) 0.041
28 to 38 −1.32 (0.43) 0.0023 −0.22 (0.41). 0.59 −0.58 (0.37) 0.12 0.60 (0.42) 0.15 −0.27 (0.32) 0.40
38 to 48 −0.68 (0.37) 0.065 0.40 (0.37) 0.27 0.047 (0.33). 0.89 1.84 (0.41) <0.0001 −0.54 (0.27) 0.046
48 to 58 −0.11 (0.13) 0.41 0.61 (0.12) <0.0001 0.37 (0.12) 0.0019 1.11 (0.14) <0.0001 −0.56 (0.09) <0.0001
58 to 68 0.95 (0.12) <0.0001 1.46 (0.11) <0.0001 1.29 (0.11) <0.0001 2.18 (0.14) <0.0001 −0.91 (0.08) <0.0001
68 to 78 1.75 (0.19) <0.0001 1.94 (0.18) <0.0001 1.87 (0.17) <0.0001 3.67 (0.24) <0.0001 −0.97 (0.12) <0.0001
78 to 98 2.30 (0.60) 0.0002 4.01 (0.64) <0.0001 3.44 (0.59) <0.0001 6.99 (0.12) <0.0001 −2.36 (0.39) <0.0001AValues are in mm2 s−1 year-−1 × 10−6 for AD, RD, and MD, in mm2 s−1 year−1 × 10−7 for PSMD, and in year−1 × 10−3 for FA.rticle 342
Beaudet et al. PSMD Changes Across Adult Lifeperformed on the white matter skeleton rather than on than the
global white-matter mask. This demonstrates the importance of
choosing a measure of MD dispersion values over a white matter
skeleton for controlling between subject variability.
In the present work, we restricted the analysis to classical DTI
metrics as only two of the contributing cohorts had high angularFrontiers in Psychiatry | www.frontiersin.org 9resolution and/or multi-shell acquisition schemes that could be
used for estimating advanced white-matter microstructural
parameters with more sophisticated models (29). Here, DWI
data processing was solely based on the classical DTI model. The
DTI model limitations are well known (24), and it has been
shown, for example, that correction for free water has a majorFIGURE 4 | ANOVA estimates and 95% confidence intervals of the effects of age on the five DT metrics for each age subcategory. Units are mm2/s/year × 10−3 for
AD, RD, and MD, mm2/s/year × 10−4 for PSMD, year × 10−3 for FA.FIGURE 5 | ANOVA estimates and 95% confidence intervals of the effects of sex (females minus males) on the five DT metrics for each age subcategory and each
data set.May 2020 | Volume 11 | Article 342
Beaudet et al. PSMD Changes Across Adult Lifeimpact on classical DTI parameter values (40, 41). However,
although investigating advanced white-matter microstructural
parameters is highly desirable, it was beyond the scope of our
study: it would require additional data sets with multi-shell
acquisition, especially for individuals aged 30 to 50 years or
over 70 years, in order to supplement existing data (8) on the
adult lifespan trajectory of these microstructural parameters.
Mixed results have been reported regarding the impact of sex
and TIV on DTI measures [(12, 25–28), see review in (3)]. Here,
we also observed mixed results across the different cohorts,
although very significant sex effects on all DTI parameters,
except FA, were uncovered when combining the entire data
set. Note, however, these sex effects were of very small size (for
PSMD, for example, omega2 = 6.7 × 10−3 for the sex effect to be
compared with 7.6 × 10−2 for the age effect), which could explain
the mixed findings in the literature, and suggests further
investigations are required in order to understand their
biological origins. TIV effects on DTI parameters are not well
established in the literature. In our study, we found that TIV was
positively correlated with all DTI parameters except for RD.
Similar to sex, TIV effects when significant were very small (for
PSMD again, omega2 = 1.5 × 10−3 for the TIV effect). Here again
additional investigations are needed to understand the origins of
these effects.
Finally, and importantly, it should be stressed that
interpretation of the results of the present study should be
taken with caution because of the cross-sectional nature of the
data that we analyzed. Numerous reports have indeed pointed
out the caveats of cross-sectional design for assessing effects of
age and demonstrated how such design may lead to spurious
findings when compared to those obtained with longitudinal
data (12, 42, 43). In the present work, there was no attempt to use
a single model to describe the variation of DTI parameters with
age over the entire adulthood period. Rather, we selected a
piecewise linear model to examine/compare age-related
changes in 10-year duration consecutive time bins, thereby
minimizing the generation bias between cohorts of nearby
categories. Understandably, such an approach does not
eradicate the intrinsic limits of our cross-sectional study. But it
should be reminded that a fully longitudinal design is quasi
impossible to implement in the context of lifespan research,
since, in practice, measures in an individual can be repeated only
a few times and at short duration intervals. As a consequence,
such longitudinal studies suffer from some of the limitations of
cross-sectional ones. This may explain why the results of theFrontiers in Psychiatry | www.frontiersin.org 10present study are compatible with those a previously published
longitudinal study (12) in which individuals aged between 20 and
84 years were observed twice 3 years apart.Adult Lifespan Profiles of Variation of
Classical DTI Parameters AD, RD, MD,
and FA
Effects of age on white-matter microstructure assessed with DTI
have been intensively investigated over the past decade from a
developmental perspective (4) as well as in a lifespan/ageing
framework (1, 3, 5, 8, 11, 12, 27, 40). Briefly, and considering
only DTI metrics estimated at the global level, AD, RD, and thus,
MD were reported to follow similar U- or better J-shape age
variation patterns, initially decreasing during childhood and
adolescence (see (4) for review) then exhibiting an accelerated
increase during the adult life (8, 12), while FA followed a reverse
profile. Our own findings agree with this body of results during
the adult life course. Raw data plots show J-shape profiles for AD,
RD, and MD, and the reverse profile for FA, as well as
acceleration of these changes during late life.
Maximum global FA values and minimum global MD, RD,
and AD values have been reported to occur before the age of 40
years (1, 5, 11, 12, 27), although large variations were found when
considering individual tracts (5, 26, 44, 45). Here, we found
extreme values for RD, MD, and FA occurring between 28 and 38
years, well in line with these previous findings. In addition, we
found that the decrease of AD in the post-adolescence period
extended into adulthood by about 10 years more than for RD and
MD, thereby uncovering heterochrony of AD and RD variations
during adulthood. Such a heterochrony during adulthood was
not detected in a previous longitudinal study (12) possibly due to
an insufficient sample size and large DTI metric variability
between individuals (as can be seen in Figure 7 of the
mentioned report). Note that two recent studies (46, 47) have
reported opposite age effects for AD (decrease) and RD
(increase) with stable MD during the 18 to 55 year age period;
however, as both studies used simple linear modeling due to
small sample sizes, no age at extreme value could be observed.
Rather, our findings are compatible with the AD-RD variation
heterochrony that has been noticed earlier during childhood and
adolescence at the individual tract level with stronger decrease
for RD than for AD (34, 44). According to these and our findings,
the AD decrease/RD increase profile (6) would occur only during
mid-adulthood.TABLE 5 | ANOVA effect of sex and TIV (estimate (standard error) and significance p value) on five DTI metrics (AD, RD, MD, PSMD, and FA evaluated across individual
FA skeletons).
AD RD MD PSMD FA
Effect estimate p estimate p estimate p estimate p estimate p
Sex (F-M) 1.13 (0.21) <0.0001 0.45 (0.21) 0.032 0.68 (0.19) 0.0005 −5.34 (0.26) <0.0001 0.04 (0.14). 0.74
TIV 1.41 (0.12) <0.0001 0.07 (0.12). 0.53 0.52 (0.01) <0.0001 1.43 (0.15) <0.0001 0.54 (0.08) <0.0001May 2020 | Volume 11 | AValues for the effects of sex are in mm2 s−1 × 10−6 for AD, RD, MD, and PSMD and in ×10−3 for FA, and for the effects of TIV are in mm2 s−1 cm−3 × 10−6 for AD, RD MD, and PSMD and in
cm−3 × 10−5 for FA.rticle 342
Beaudet et al. PSMD Changes Across Adult LifePSMD Is a Diffusion Imaging Phenotype
With a Profile of Variation Across the Adult
Lifespan That Differs From That of Other
DTI Parameters
The distribution of PSMD values observed for the different
cohorts and age categories of the present study are consistent
with the few comparable data reported in the literature for older
participants (no data are available in young adults). For example,
Baykara et al. reported in their pioneering article a PSMD
median value around 3.0 (in mm2 s−1 × 10−4, range [2.5, 4.9])
in a sample of healthy individuals aged 60 to 80 years drawn from
the ASPF cohort [see Table 2 of Baykara et al. (20)], values that
are comparable to those reported in Table 3D of our study in
subsamples of other cohorts of similar age category. Similarly,
Wei et al. (21) recently reported a PSMD average value of 2.4 ×
10−4 mm2 s−1 in a sample of healthy controls aged around 60
years. In both studies, PSMD CVs were close to 10%, a value
again similar to those observed in our own study. That the CV of
PSMD is two to three times larger than the CVs of other DTI
metrics could be expected since PSMD is a dispersion rather than
a central tendency statistic. Moreover, the larger increase in
PSMD CV as age advances (as compared to the other DTI
metrics) indicates that this phenotype should be used with
caution especially during the late life period. However, it is
important to note that the CV of PSMD was found to be quite
stable across cohorts with similar age ranges.
The main goal of the present study was to document the
profile of PSMD evolution across age bands during adulthood. In
this respect, and the proviso that the data we gathered were not
longitudinal, our results show that PSMD increases continuously
from post-adolescence to late adult life, that this increase is
accelerating at later ages, and that this acceleration is larger than
for the other DTI metrics. As there are no available data of
PSMD in childhood and adolescence, it is not possible to decide
whether the lifetime PSMD evolution profile is similar to those of
AD, RD, MD, i.e. with a decrease during childhood that reaches
the minimum value before adulthood, or if it shows continuous
increase throughout the lifespan. Nevertheless, it remains the
case that the continuous and accelerating increase of PSMD
during adulthood is an indication that it is an adequate and
potentially valuable marker of white matter ageing. In particular,
it is notable that PSMD increases during early adulthood when
the other DTI metrics variations appear to be still undergoing
late maturational processes.
The biological mechanisms of the origin of PSMD evolution
with age are at present unknown, but one can think of several
reasons why PSMD may be more prone to increase with age as
compared with the other metrics. First, it is important to
remember that PSMD is a measure of MD values dispersion
across a skeleton of white matter. As such, it will be directly
affected by differences across MD values of the individual tracts.
Consequently, regional heterogeneity as well as heterochrony in
MD values of the fiber tracts will result in higher PSMD values
more than in average MD values. Second, MD itself is a weighted
average of AD (1/3) and RD (2/3) values, and thus MD value
dispersion will also be affected by heterochrony in AD and RDFrontiers in Psychiatry | www.frontiersin.org 11variations with age. Overall, what possibly makes PSMD an early
and sensitive imaging marker of ageing is that it captures
multiple sources of heterogeneity in white matter water
diffusion parameters. With this regard, it would be interesting
to investigate variations in the pattern of MD dispersion at the
regional level using tract-based DTI metrics since it is well
established that heterochrony is a major feature of the
development and aging of the different fiber tracts [see for
example (5, 8, 26, 44)]. Accordingly, variations of PSMD value
provide only a gross and possibly biased estimate of the white
matter-microstructure dynamics. We did not implement
regional analysis as our study focused on PSMD that is by
definition a dispersion statistic over the entire white matter
skeleton. Nevertheless, a regional approach would certainly be
interesting and feasible since peak width of MD values could be
measured on a white-matter skeleton at the tract level in the
same manner as it has been done for other DTI metrics (see (34,
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